{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:00:01Z","timestamp":1795089601513,"version":"4.10.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s12276-018-0195-x","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T08:06:48Z","timestamp":1547194008000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"51","author":[{"given":"Woori","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonhong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlm","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Jekarl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojin","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungja","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nack-Gyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-0168","authenticated-orcid":false,"given":"Myungshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"195_CR1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3324\/haematol.2009.012047","volume":"94","author":"CG Mullighan","year":"2009","unstructured":"Mullighan, C. G. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica 94, 1338\u20131340 (2009).","journal-title":"Haematologica"},{"key":"195_CR2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui, C. H. & Evans, W. E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166\u2013178 (2006).","journal-title":"N. Engl. J. Med."},{"key":"195_CR3","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Vlierberghe Van","year":"2012","unstructured":"Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398\u20133406 (2012).","journal-title":"J. Clin. Invest."},{"key":"195_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.22416","volume":"56","author":"K Karrman","year":"2017","unstructured":"Karrman, K. & Johansson, B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 56, 89\u2013116 (2017).","journal-title":"Genes Chromosomes Cancer"},{"key":"195_CR5","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.18632\/oncotarget.2218","volume":"6","author":"M Neumann","year":"2015","unstructured":"Neumann, M. et al. Mutational spectrum of adult T-ALL. Oncotarget 6, 2754\u20132766 (2015).","journal-title":"Oncotarget"},{"key":"195_CR6","first-page":"832","volume":"57","author":"A Batova","year":"1997","unstructured":"Batova, A. et al. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 57, 832\u2013836 (1997).","journal-title":"Cancer Res."},{"key":"195_CR7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver, L. & Ferrando, A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat. Rev. Cancer 16, 494\u2013507 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"195_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gcc.22039","volume":"52","author":"V Grossmann","year":"2013","unstructured":"Grossmann, V. et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer 52, 410\u2013422 (2013).","journal-title":"Genes Chromosomes Cancer"},{"key":"195_CR9","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand, A. et al. Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J. Clin. Oncol. 31, 4333\u20134342 (2013).","journal-title":"J. Clin. Oncol."},{"key":"195_CR10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"195_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith, E. et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 10, 147\u2013156 (2009).","journal-title":"Lancet Oncol."},{"key":"195_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","volume":"166","author":"K Patrick","year":"2014","unstructured":"Patrick, K. et al. Outcome for children and young people with early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br. J. Haematol. 166, 421\u2013424 (2014).","journal-title":"Br. J. Haematol."},{"key":"195_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ejh.12238","volume":"92","author":"A Chopra","year":"2014","unstructured":"Chopra, A. et al. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur. J. Haematol. 92, 211\u2013218 (2014).","journal-title":"Eur. J. Haematol."},{"key":"195_CR14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12185-014-1513-2","volume":"99","author":"J Park","year":"2014","unstructured":"Park, J. et al. Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea. Int. J. Hematol. 99, 279\u2013287 (2014).","journal-title":"Int. J. Hematol."},{"key":"195_CR15","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/leu.2010.217","volume":"24","author":"S Lee","year":"2010","unstructured":"Lee, S. et al. Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia. Leukemia 24, 2110\u20132119 (2010).","journal-title":"Leukemia"},{"key":"195_CR16","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/pbc.26136","volume":"63","author":"JW Lee","year":"2016","unstructured":"Lee, J. W. et al. Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients. Pediatr. Blood Cancer 63, 1966\u20131973 (2016).","journal-title":"Pediatr. Blood Cancer"},{"key":"195_CR17","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","volume":"121","author":"M Neumann","year":"2013","unstructured":"Neumann, M. et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 121, 4749\u20134752 (2013).","journal-title":"Blood"},{"key":"195_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157\u2013163 (2012).","journal-title":"Nature"},{"key":"195_CR19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3324\/haematol.2015.129692","volume":"100","author":"JB Kunz","year":"2015","unstructured":"Kunz, J. B. et al. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation. Haematologica 100, 1442\u20131450 (2015).","journal-title":"Haematologica"},{"key":"195_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.3","volume":"7","author":"P Richter-Pechanska","year":"2017","unstructured":"Richter-Pechanska, P. et al. Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood Cancer J. 7, e523 (2017).","journal-title":"Blood Cancer J."},{"key":"195_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","volume":"368","author":"T Nobori","year":"1994","unstructured":"Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753\u2013756 (1994).","journal-title":"Nature"},{"key":"195_CR22","first-page":"837","volume":"57","author":"JG Herman","year":"1997","unstructured":"Herman, J. G. et al. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57, 837\u2013841 (1997).","journal-title":"Cancer Res."},{"key":"195_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.10188","volume":"37","author":"R Bertin","year":"2003","unstructured":"Bertin, R. et al. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 37, 44\u201357 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"195_CR24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","volume":"113","author":"S Sulong","year":"2009","unstructured":"Sulong, S. et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 113, 100\u2013107 (2009).","journal-title":"Blood"},{"key":"195_CR25","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood.V95.6.1942","volume":"95","author":"IH Wong","year":"2000","unstructured":"Wong, I. H., Ng, M. H., Huang, D. P. & Lee, J. C. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood 95, 1942\u20131949 (2000).","journal-title":"Blood"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/1097-0142(20010615)91:12<2222::AID-CNCR1252>3.0.CO;2-R","volume":"91","author":"CS Chim","year":"2001","unstructured":"Chim, C. S., Tam, C. Y., Liang, R. & Kwong, Y. L. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer 91, 2222\u20132229 (2001).","journal-title":"Cancer"},{"key":"195_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00432-015-2063-6","volume":"142","author":"H Mai","year":"2016","unstructured":"Mai, H. et al. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia. J. Cancer Res. Clin. Oncol. 142, 497\u2013504 (2016).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"195_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cancergencyto.2009.06.013","volume":"195","author":"M Kim","year":"2009","unstructured":"Kim, M. et al. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet. Cytogenet. 195, 59\u201365 (2009).","journal-title":"Cancer Genet. Cytogenet."},{"key":"195_CR29","first-page":"881","volume":"91","author":"D Mirebeau","year":"2006","unstructured":"Mirebeau, D. et al. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 91, 881\u2013885 (2006).","journal-title":"Haematologica"},{"key":"195_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-015-0138-0","volume":"8","author":"K Karrman","year":"2015","unstructured":"Karrman, K. et al. Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A. J. Hematol. Oncol. 8, 42 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"195_CR31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/leu.2011.33","volume":"25","author":"L Yu","year":"2011","unstructured":"Yu, L. et al. Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia. Leukemia 25, 1042\u20131046 (2011).","journal-title":"Leukemia"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","volume":"98","author":"CJ Schwab","year":"2013","unstructured":"Schwab, C. J. et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica 98, 1081\u20131088 (2013).","journal-title":"Haematologica"},{"key":"195_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10635","volume":"7","author":"EA Hungate","year":"2016","unstructured":"Hungate, E. A. et al. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology. Nat. Commun. 7, 10635 (2016).","journal-title":"Nat. Commun."},{"key":"195_CR34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00432-016-2174-8","volume":"142","author":"V Schafer","year":"2016","unstructured":"Schafer, V. et al. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. J. Cancer Res. Clin. Oncol. 142, 1641\u20131650 (2016).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"195_CR35","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2016.01.064","volume":"14","author":"E Danis","year":"2016","unstructured":"Danis, E. et al. Ezh2 controls an early hematopoietic program and growth and survival signaling in early T cell precursor acute lymphoblastic leukemia. Cell Rep. 14, 1953\u20131965 (2016).","journal-title":"Cell Rep."},{"key":"195_CR36","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472\u20131478 (2014).","journal-title":"Nat. Med."},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2016.29","volume":"30","author":"L Scourzic","year":"2016","unstructured":"Scourzic, L. et al. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice. Leukemia 30, 1388\u20131398 (2016).","journal-title":"Leukemia"},{"key":"195_CR38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ng.3610","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat. Genet. 48, 1014\u20131023 (2016).","journal-title":"Nat. Genet."},{"key":"195_CR39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40164-015-0024-z","volume":"4","author":"J Gao","year":"2015","unstructured":"Gao, J., Chen, Y. H. & Peterson, L. C. GATA family transcriptional factors: emerging suspects in hematologic disorders. Exp. Hematol. Oncol. 4, 28 (2015).","journal-title":"Exp. Hematol. Oncol."},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","volume":"122","author":"A Perez-Garcia","year":"2013","unstructured":"Perez-Garcia, A. et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood 122, 2425\u20132432 (2013).","journal-title":"Blood"},{"key":"195_CR41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2010.08532.x","volume":"152","author":"E Kuchinskaya","year":"2011","unstructured":"Kuchinskaya, E. et al. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol. Br. J. Haematol. 152, 615\u2013622 (2011).","journal-title":"Br. J. Haematol."},{"key":"195_CR42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3324\/haematol.2009.007526","volume":"95","author":"D Krieger","year":"2010","unstructured":"Krieger, D. et al. Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A\/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia. Haematologica 95, 158\u2013162 (2010).","journal-title":"Haematologica"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0195-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:19Z","timestamp":1684617019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0195-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1038\/s12276-018-0195-x","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}